PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Consolidated Net Profit | ₹18 Cr | ₹-186 Cr | ₹376 Cr | ₹835 Cr |
What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹18 Cr |
Mar2023 | ₹-186 Cr |
Mar2022 | ₹376 Cr |
Mar2021 | ₹835 Cr |
How is Consolidated Net Profit of PIRAMAL PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹18 Cr | Positive | |
Mar2023 | ₹-186 Cr | Negative | |
Mar2022 | ₹376 Cr | -54.98 | |
Mar2021 | ₹835 Cr | - |
Compare Consolidated Net Profit of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹30,544.1 Cr | -1.1% | -6.1% | 62.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,699.0 Cr | 0.6% | -4.6% | 20.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,584.0 Cr | 9.8% | 4.5% | 64.7% | Stock Analytics | |
CIPLA | ₹116,022.0 Cr | -2.9% | -3.9% | 1.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,463.0 Cr | 0.9% | -10.4% | 0.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,434.8 Cr | 0.9% | -0.3% | 27.9% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | -1.1% |
-6.1% |
62.9% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses